Get the Stockscreener App
7.305
1.55%
-0.205
After Hours:
7.29
-0.015
-0.21%
Mink Therapeutics Inc Stock (INKT) Forecast
The Mink Therapeutics Inc (INKT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.2419, representing a -96.69% decrease from the current price of $7.305. The highest analyst price target is $0.4119, and the lowest is $0.072.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month INKT Price Target
Average 0.8243
(-88.72% Downside)
Is Mink Therapeutics Inc (INKT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.33 | Neutral |
| STOCH(9,6) | 55.00 | Neutral |
| STOCHRSI(14) | 69.11 | Neutral |
| MACD(12,26) | -0.1453 | Buy |
| ADX(14) | 15.41 | Neutral |
| William %R | -43.24 | Neutral |
| CCI(14) | -19.81 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.3529
Sell
|
7.3265
Sell
|
| MA20 |
7.3871
Sell
|
7.4169
Sell
|
| MA50 |
7.8571
Sell
|
7.7355
Sell
|
| MA100 |
8.3955
Sell
|
7.9268
Sell
|
| MA200 |
7.8036
Sell
|
8.1748
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, INKT could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on INKT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 47.33 indicates that INKT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55 indicates that INKT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 69.11 indicates that INKT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.41 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -19.81 indicates that INKT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term INKT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Mink Therapeutics Inc financial reports and earnings history, Mink Therapeutics Inc (INKT) stock could reach $6.4177 by 2030, $7.3341 by 2040 and $21.57 by 2050. See the projected annual prices until 2050 of the Mink Therapeutics Inc stock below:
- Mink Therapeutics Inc (INKT) is expected to reach an average price of $2.904 in 2035, with a high prediction of $3.1841 and a low estimate of $2.9253. This indicates an $-60.25% rise from the last recorded price of $7.305.
- Mink Therapeutics Inc (INKT) stock is projected to chart a bullish course in 2040, with an average price target of $7.2497, representing an $-0.76% surge from its current level. The forecast ranges from a conservative $7.3497 to a sky-high $7.3341.
- Our analysts predict Mink Therapeutics Inc (INKT) to jump 76.65% by 2045, soaring from $13.03 to an average price of $12.90, potentially reaching $13.29. While $13.03 is the low estimate, the potential upside is significant.
- Mink Therapeutics Inc (INKT) stock is expected to climb by 2050, reaching an average of $20.60, a $182.02% jump from its current level. However, a wide range of estimates exists, with high and low targets of $21.57 and $20.64, respectively, highlighting the market's uncertainty.
Mink Therapeutics Inc Stock (INKT) Year by Year Forecast
Mink Therapeutics Inc Stock (INKT) Price Forecast for 2025
Mink Therapeutics Inc Stock (INKT) is expected to reach an average price of $0.8636 in 2025, with a high prediction of $1.7235 and a low estimate of $0.00382. This indicates an -88.18% fall from the last recorded price of $7.305.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $0.2509 | $0.072 | $0.4119 | -96.56% |
| July, 2025 | $0.1961 | $0.0359 | $0.68 | -97.32% |
| August, 2025 | $0.1282 | $0.0318 | $0.3541 | -98.25% |
| September, 2025 | $0.0102 | $0.00382 | $0.2062 | -99.86% |
| October, 2025 | $0.0346 | $0.0163 | $0.3843 | -99.53% |
| November, 2025 | $0.0675 | $0.0236 | $0.4443 | -99.08% |
| December, 2025 | $0.00741 | $0.00741 | $0.5846 | -99.90% |
Mink Therapeutics Inc Stock (INKT) Price Forecast for 2026
The predicted value for Mink Therapeutics Inc (INKT) in 2026 is set at an average of $0.8224. Estimates vary from a peak of $1.6447 to a trough of $0.000198, indicating an -88.74% surge from the present price of $7.305.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.8647 | $0.0106 | $1.6447 | -88.16% |
| February, 2026 | $0.2068 | $0.0388 | $1.2027 | -97.17% |
| March, 2026 | $0.2789 | $0.0148 | $0.4089 | -96.18% |
| April, 2026 | $0.131 | $0.019 | $0.3369 | -98.21% |
| May, 2026 | $0.2189 | $0.225 | $0.1489 | -97.00% |
| June, 2026 | $0.2968 | $0.2759 | $0.2848 | -95.94% |
| July, 2026 | $0.1767 | $0.2448 | $0.1827 | -97.58% |
| August, 2026 | $0.1446 | $0.1887 | $0.1306 | -98.02% |
| September, 2026 | $0.2211 | $0.0785 | $0.1145 | -96.97% |
| October, 2026 | $0.0734 | $0.1091 | $0.1564 | -99.00% |
| November, 2026 | $0.0417 | $0.000429 | $0.1047 | -99.43% |
| December, 2026 | $0.1546 | $0.000198 | $1.0518 | -97.88% |
Mink Therapeutics Inc Stock (INKT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Mink Therapeutics Inc (INKT) is $2.1663, with a high forecast of $4.2838 and a low forecast of $0.0489. This indicates an -70.34% decrease from the last price of $7.305.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1404 | $0.0489 | $0.2319 | -98.08% |
| February, 2027 | $2.5369 | $2.5529 | $1.7629 | -65.27% |
| March, 2027 | $3.1366 | $3.2466 | $3.1887 | -57.06% |
| April, 2027 | $3.2324 | $3.5506 | $3.2985 | -55.75% |
| May, 2027 | $3.6082 | $3.4665 | $3.1403 | -50.61% |
| June, 2027 | $3.588 | $3.484 | $3.5961 | -50.88% |
| July, 2027 | $4.4238 | $3.6319 | $4.2838 | -39.44% |
| August, 2027 | $3.9596 | $4.1517 | $4.0077 | -45.80% |
| September, 2027 | $4.0893 | $4.0792 | $4.0154 | -44.02% |
| October, 2027 | $3.9152 | $4.0273 | $3.9667 | -46.40% |
| November, 2027 | $2.491 | $2.901 | $3.2892 | -65.90% |
| December, 2027 | $2.8307 | $2.6128 | $2.6107 | -61.25% |
Mink Therapeutics Inc Stock (INKT) Price Forecast for 2028
In 2028, Mink Therapeutics Inc (INKT) is projected to reach an average price of $1.8421, with a high projection of $2.7236 and a low estimate of $0.9606. This indicates an -74.78% fall from the last price of $7.305.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.7665 | $2.8947 | $2.7236 | -62.13% |
| February, 2028 | $1.9923 | $2.0323 | $2.5305 | -72.73% |
| March, 2028 | $2.2021 | $2.0081 | $1.9521 | -69.86% |
| April, 2028 | $1.9679 | $2.2079 | $1.946 | -73.06% |
| May, 2028 | $1.9476 | $2.0094 | $1.9297 | -73.34% |
| June, 2028 | $1.8585 | $1.9832 | $1.9619 | -74.56% |
| July, 2028 | $1.9643 | $1.8925 | $1.6674 | -73.11% |
| August, 2028 | $2.099 | $1.7811 | $1.8232 | -71.27% |
| September, 2028 | $1.7748 | $1.7609 | $1.7269 | -75.70% |
| October, 2028 | $0.8306 | $0.9606 | $1.6122 | -88.63% |
| November, 2028 | $1.4804 | $1.3246 | $1.3604 | -79.73% |
| December, 2028 | $1.3762 | $1.3722 | $1.2743 | -81.16% |
Mink Therapeutics Inc Stock (INKT) Price Forecast for 2029
The 2029 price forecast for Mink Therapeutics Inc Stock (INKT) is $3.4916 on average, with a high prediction of $6.3981 and a low estimate of $0.5852. This represents an -52.20% decrease from the previous price of $7.305.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.5959 | $1.498 | $1.4659 | -78.15% |
| February, 2029 | $1.6418 | $1.6468 | $1.5378 | -77.53% |
| March, 2029 | $1.4276 | $1.5976 | $1.6197 | -80.46% |
| April, 2029 | $1.4034 | $1.4934 | $1.4455 | -80.79% |
| May, 2029 | $1.2031 | $1.2731 | $1.3273 | -83.53% |
| June, 2029 | $1.2855 | $1.1971 | $1.1789 | -82.40% |
| July, 2029 | $1.0657 | $1.1014 | $1.2029 | -85.41% |
| August, 2029 | $0.91 | $0.9198 | $0.9968 | -87.54% |
| September, 2029 | $0.6756 | $0.6903 | $0.8579 | -90.75% |
| October, 2029 | $5.6825 | $0.5852 | $3.7825 | -22.21% |
| November, 2029 | $6.5662 | $5.8344 | $5.7262 | -10.11% |
| December, 2029 | $6.3099 | $6.4199 | $6.3981 | -13.62% |
Mink Therapeutics Inc Stock (INKT) Price Forecast for 2030
Mink Therapeutics Inc Stock (INKT) is expected to reach an average price of $5.7064 in 2030, with a high forecast of $7.1507 and a low forecast of $4.2622. This signifies an -21.88% decrease from the last price of $7.305.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.3396 | $6.5497 | $6.4177 | -13.22% |
| February, 2030 | $6.7833 | $6.7873 | $6.4933 | -7.14% |
| March, 2030 | $6.527 | $6.441 | $6.5892 | -10.65% |
| April, 2030 | $7.2907 | $6.5529 | $7.1507 | -0.20% |
| May, 2030 | $6.7203 | $6.8903 | $6.8566 | -8.00% |
| June, 2030 | $6.794 | $6.8019 | $6.7381 | -6.99% |
| July, 2030 | $6.1337 | $6.6736 | $6.6534 | -16.03% |
| August, 2030 | $5.0474 | $5.3273 | $4.9814 | -30.91% |
| September, 2030 | $5.3011 | $5.1192 | $5.0811 | -27.43% |
| October, 2030 | $4.9607 | $5.0206 | $5.1399 | -32.09% |
| November, 2030 | $4.3544 | $4.3585 | $4.6267 | -40.39% |
| December, 2030 | $4.4381 | $4.2622 | $4.1881 | -39.25% |
3.48%
1.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):